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Molecular Docking Study of the Interactions between Plasmodium falciparum 
Lactate Dehydrogenase and 4-aminoquinoline Hybrids 
(Kajian Dok Molekul Mengenai Interaksi antara Hibrid 4-aminokuinolina dan Plasmodium falciparum Laktat 
Dehidrogenase)




Malaria is a potentially deadly disease with many anti-malarial drugs have been rendered ineffective due to 
Plasmodium falciparum resistance concern. Plasmodium falciparum lactate dehydrogenase (PfLDH) enzyme is a crucial 
malaria parasite enzyme involved in the glycolytic pathway, thus, has been considered as a potential molecular 
target. Initially, molecular docking was performed using AutoDock Vina, Molegro Virtual Docker, and CDOCKER 
software to investigate the molecular interactions of 4-aminoquinoline antimalarial hybrids compounds with PfLDH 
enzyme. All ten 4-aminoquinoline hybrids derivatives docked to the PfLDH binding site. The results showed that these 
compounds exhibited either comparable or higher binding affinity than the reference drug chloroquine, amodiaquine, 
and hydroxychloroquine. Visually, some of the compounds possessed functional binding interactions, possibly due to 
their similar structural conformation and binding interactions of chloroquine in the binding site. Apart from that, the 
docking results also suggest that these compounds potentially promote additional hydrogen-bonding interactions with 
the residues in the binding site. Interestingly, the compounds also predicted to interact with essential PHE52, VAL26, 
ILE54, ILE119, and ALA98 residues, which are required to act as a competitive inhibitor for this glycolytic enzyme. 
Keywords: 4-aminoquinoline; malaria; molecular docking; Plasmodium falciparum lactate dehydrogenase (PfLDH) 
enzyme
ABSTRAK
Malaria merupakan antara penyakit yang boleh menyebabkan kematian dengan peningkatan kerintangan ubat-ubatan 
anti-malaria sedia ada. Enzim Plasmodium falciparum dehidrogenase (PfLDH) merupakan enzim sasaran yang 
terlibat dalam laluan glikolitik. Oleh itu, kajian dok molekul telah dijalankan menggunakan perisian AutoDock Vina, 
Molegro Virtual Docker dan CDOCKER untuk mengkaji interaksi molekul antara 4-aminokuinolina antimalaria hibrid 
terhadap PfLDH enzim. Kesemua sepuluh sebatian hibrid dilihat sesuai untuk didok menggunakan kedua-dua perisian 
dan menunjukkan pengikatan keafinan yang baik dan setanding dengan pengikatan keafinan sebatian klorokuina, 
amodiakuina dan hidrosiklorokuina. Pengikatan keafinan yang baik dan setanding klorokuina disebabkan persamaan 
struktur bentuk dengan klorokuina pada tapak pengikat selain kemampuan menambah ikatan hidrogen. Sebatian juga 
berinteraksi dengan asid amino yang penting sebagai perencat bersaing untuk enzim glikolitik. Semua asid amino 
yang penting termasuklah PHE52, VAL26, ILE54, ILE119 dan ALA98.
Kata kunci: Dok molekul; enzim Plasmodium falciparum dehidrogenase (PfLDH); malaria; 4-aminokuinolina
INTRODUCTION
Malaria, a widespread tropical disease caused by the 
protozoan parasite of the genus Plasmodium, was 
responsible for an estimated 228 million cases in 2018, 
with the vast majority occurring in WHO African region 
(93%) followed by WHO South-East Asia Region (3.4%) 
mainly in children under five years of age. Plasmodium 
falciparum is the most prevalent malaria parasite in 
sub-Saharan Africa, accounting for 99.7% of estimated 
malaria cases in 2018. Outside of Africa, Plasmodium 
vivax is the predominant parasite representing 53% of 
malaria cases (WHO 2019). For decades, quinoline based 
antimalarials such as chloroquine used for the treatment of 
malaria due to its low cost, safety, and efficacy. However, 
due to its extensive global use, chloroquine-resistant 
Plasmodium falciparum and Plasmodium vivax have now 
been reported in every endemic malaria country, thus 
complicates the treatment. In response to this, a vast number 
of modified chloroquine molecules designed to overcome 
resistance in malaria.
An idea for chloroquine mechanism of action 
comes from the observation that it is active only against 
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the erythrocytic stages of parasites. The previous study 
showed that chloroquine could potentially interfere 
with the parasite feeding process (Waingeh et al. 2013). 
Targeting enzymes responsible through glycolytic 
pathways is thought to be an essential drug target for 
malaria treatment. For example, lactate dehydrogenase 
(LDHs) is an essential enzyme for parasite survival as it 
catalyzes the reduction of the keto group in pyruvate to 
hydroxyl with the concomitant oxidation of NADH to 
NAD+. Furthermore, protozoal LDHs have structural and 
kinetic differences to their mammalian equivalents, which 
will be beneficial for the development of drug selectivity 
(Chaikuad et al. 2005). 
Chloroquine binds in or near to the cofactor binding 
site of PfLDH, suggesting the compound act as an inhibitor 
for this enzyme (Read et al. 1999; Waingeh et al. 2013). 
The computer-aided drug design approach, molecular 
docking was utilized in this study to investigate the 
binding interactions of designed antimalarials hybrids 
compounds with the residues in the active site of PfLDH. 
Besides, this study also aimed to search for the best 
orientation of the ligand-enzyme complex with the lowest 
binding energy. Thus, the basis of the distinct activity 
profile of 4-aminoquinoline hybrid proposed towards 
the PfLDH enzyme realized. In general, the molecular 
docking process allows for better understanding of 
newly designed molecules to their target protein molecules 
besides providing an economical identification approach 
for potential compounds (Shadrack et al. 2016). 
MATERIALS AND METHODS
MOLECULAR DOCKING
Ten derivatives of 4-aminoquinoline hybrids prepared in 
this study (Figure 1). The ligand’s 3D structures were drawn 
using ChemDraw Professional 15.0 and minimized to 
stabilize their structural energy. The protein crystal 
structure of the P. falciparum lactate dehydrogenase 
(PfLDH) enzyme with cofactor retrieved from the Protein 
data bank (PDB ID:1CET, resolution: 2.05 Å). The protein 
crystal structure was pre-treated before the docking 
process. The respective ligands, non-protein molecules, 
and water molecules were removed and employed as 
receptors for the docking analysis. Discovery Studio 
2016 (Accelrys Inc. San Diego, CA, USA) used for the 
protein and ligand preparation. As for the ligand structure 
preparation, the 2D structure of antimalarial hybrids 
drawn in the ChemDraw program before further energy 
minimization using the same software. Subsequently, the 
2D ligand structures converted to PDB files. The PDB 
files prepared for docking in AutoDock Vina, Molegro 
Virtual Docker, and CDOCKER software.
AUTODOCK VINA
Each of the protein crystal structure and ligands were 
loaded and converted to pdbqt format, respectively. 
Hydrogen and partial charges added, and the target site 
assigned along with the dimension.  Ligands were also 
loaded and converted into pdbqt format. The best free 
energy of binding values obtained by using the command 
prompt to run the docking. The docking visualization of 
ligands and PfLDH visualized in Discovery Studio 2.5.5 
(Trott & Olson 2010).
MOLEGRO VIRTUAL DOCKER(MVD)
Molegro virtual docker uses cavity detection algorithm 
to detect potential binding site which has an active region 
to bind the drug. Protein crystal structure and ligands 
imported into the worksheet. Under the protein and 
ligand preparation tab, all features were assigned to 
‘Always’ to ensure that MVD will do all preparation. 
Prediction of the binding site on the protein was made 
by selecting ‘preparation’ and ‘detect cavities’ parameter. 
Reference ligand and docking template of reference drugs 
set to get specific binding of the newly designed drugs. 
Docking made by choosing the smallest grid resolution 
with ten poses generation. The best energy of binding 
values obtained. The docking visualization of ligands and 
PfLDH visualized in the workspace and Discovery Studio 
2.5.5. (Thomsen & Christensen 2006). 
CDOCKER
CDOCKER algorithm is a grid-based molecular docking 
method. All ten newly designed compounds were submitted 
to CHARMm (Chemistry at HARvard Macromolecular 
Mechanics) force field for structure refinement. All 
ligands were energy minimized using the CHARMm 
force field to make stable conformation of protein with an 
energy gradient of 0.01 kcal/mol/ Å. For each final pose, 
the CHARMm energy obtained as a result of interaction 
energy plus ligand strain calculated. The docked 
conformation with the lowest interaction energy was 
selected. The docking visualization of ligands and PfLDH 
visualized in Discovery Studio 2.5.5. (Wu et al. 2003). 
DRUG LIKENESS ASSESSMENT
Drug-likeness of ten derivatives of 4-aminoquinoline 
hybrids evaluated further using Lipinski’s rule of five. It 
is an empirical rule of thumb to evaluate physicochemical 
properties and refine drug ability for small molecules. 
ChemDraw Professional 15.0 software and Sanjeevini 
web server were utilised to calculate and predict the value 
of LogP, hydrogen bond donor and acceptor as well as the 
molecular weight (Jayaram et al. 2012). These hybrids 
should compose of no more than five hydrogen bond 
donors and ten hydrogen bond acceptors. The increasing 
number of hydrogen bonds may reduce partitioning 
from the aqueous phase into the lipid bilayer membrane 
for permeation by passive diffusion. Furthermore, the 
compound’s molecular mass must be less than 500 Daltons 
as increasing molecular weight reduces the compound 
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concentration at the surface of the intestinal epithelium, 
hence lessens the absorption. An octanol-water partition 
coefficient Log P must not be greater than five to prevent 










































































































FIGURE 1. Ten derivatives of 4-aminoquinoline hybrid compounds 
(1-10) utilized in the in silico study
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RESULTS AND DISCUSSION
Molecular docking is a virtual tool intended to find the 
best binding orientation of newly designed molecules to 
their target protein molecules. It is useful to predict the 
binding affinity as well as the biological efficacy of small 
molecules (Kitchen et al. 2004). Thus, to gain insights 
into the critical structural needed and the basis of the 
distinct activity profile of ten newly proposed and designed 
4-aminoquinoline hybrids toward the PfLDH enzyme, a 
molecular docking study was conducted. For the selection 
of protein target, 1CET  protein (resolution of 2.05 Å)  was 
used for it provides crystal structure of complex formed 
between chloroquine and pfLDH enzyme. The structure 
of this enzyme-inhibitor complex provides a template for 
which the 4-aminoquinoline hybrids to be docked (Read 
et al. 1999). In the beginning, the chloroquine crystal 
ligand was docked to the protein crystal structure of 1CET 
protein to verify the accuracy and reliability of software 
to be used in this study (Chaikuad et al. 2005). Figure 2 
shows the superposition of chloroquine crystal structure 
as observed in the crystallographic structure of PfLDH, 
and the best chloroquine docking conformation obtained 
in the same binding site as predicted by AutoDock Vina, 
Molegro Virtual Docker, and CDOCKER, respectively. 
All software was capable of accurately predicting the 
chloroquine binding orientation, as shown in the ligand-
protein complex crystal structure. The result suggests that 
all three software were suitable to be used in subsequent 
docking study. The RMSD generated out from the 
superposition of the crystal ligand and docked ligand were 
of 1.36Å(AutoDock Vina), 1.67 Å (CDOCKER), and 0.72 
Å (Molegro Virtual Docker), respectively.
The docking results showed that all ten newly 
designed 4-aminoquinoline hybrid compounds exhibited 
higher binding affinity as compared to chloroquine, 
amodiaquine, and hydroxychloroquine. Table 1 
summarizes the molecular docking results based on 
the most favourable conformation and highest binding 
affinity of ten 4-aminoquinoline hybrids. Binding energy 
is the primary parameter that is generated that guides us 
on the strength and affinity between ligand and receptor. 
4-Aminoquinoline with favourable binding energy 
proposed to be bonded stronger. The result predicted 
indicated that the dock scores of all ten 4-aminoquinoline 
hybrids were consistent in terms of their high binding 
affinity. Apart from that, all the hybrids displayed higher 
binding affinity than chloroquine, amodiaquine, and 
hydroxychloroquine. This study may, therefore, serve as 
an essential tool for accessing the antimalarial potential 
of newly design 4-aminoquinoline hybrid as a potential 
inhibitor for the PfLDH enzyme.  
As illustrated in Figure 3, compound 8 exhibited 
the highest binding affinity of -7.0 kcal/mol compared 
to chloroquine (-5.9 kcal/mol), amodiaquine (-5.6 kcal/
mol) and hydroxychloroquine (-5.9 kcal/mol) using 
Autodock Vina. Using MVD, compound 8 exhibited 
Moldock score with a binding energy of -74.66 kcal/
mol while the reference established drugs chloroquine, 
amodiaquine and hydroxychloroquine with -61.71 kcal/
mol, -66.31 kcal/mol and -56.68 kcal/mol, respectively. 
On the other hand, CDOCKER showed not many 
differences in term of binding energy for all ten newly 
designed 4-aminoquinoline hybrid when compared 
with the reference established drugs used. Chloroquine, 
amodiaquine and hydroxychloroquine exhibited -30.81, 
-32.27 and -32.35 kcal/mol, respectively, while compound 
8 with -32.82 kcal/mol.
The designed hybrids, compound 8, was selected 
for further visualization and analysis due to its favourable 
binding energy profile. The binding mode of compound 8 
in 2D in the 3D poses of bound ligand molecules revealed 
the best molecular orientation relative to the structure 
of the receptor, as shown in Figure 3. Table 2 indicates 
various interactions involved between the protein and 
compound 8 bindings, especially polar hydrogen bonding 
interaction. For example, residue ASN83 has established 
hydrogen bonding interaction with the amines functional 
group in compound 8, which could be responsible for the 
higher binding affinity. Molecular interaction revealed 
well-defined binding between binding site residue of 
receptor studied and newly designed 4-aminoquinoline 
hybrids. Such interactions brought about the excellent 
quality of the complex formed between the receptor and 
the ligand molecule. Analysis of docking interactions 
then further supports the importance of 4-aminoquinoline 
moiety in protein-ligand interaction (O’Neill et al. 2006). 
Hybridization of pyranopyrazole moiety with different 
substituent then further lead toward the formation of 
the compound with different conformation suitable for 
binding. Pyranopyrazole moiety increased the strength of 
interaction by forming an additional hydrogen bond. This 
bond then facilitated to afford even stronger interaction of 
the ligand with the receptor studied. 
Amino acids responsible for the binding of 
chloroquine in the PfLDH binding site are PHE 52, 
VAL26, ALA98, ILE54, GLU122, and ILE119. Amino 
acid residue forms a binding groove near the surface of 
the enzyme. Some of these amino acids, such as ALA98, 
ILE54, and ILE119, are the same responsible for 
NADH binding in its binding site (Read et al. 1999). 
4-Aminoquinoline hybrids also make specific interactions 
in the PfLDH binding site. It is noteworthy that the 
binding interaction formed involving those important 
amino acids responsible in the chloroquine interaction. 
Those amino acids include PHE52, VAL26, ILE54, 
ILE119, PHE 100, ASN83, and ALA98, thus suggesting 
the potential activity of newly design hybrids (Figure 4).
DRUG LIKENESS ASSESSMENT
Drug likeness assessment of ten newly designed 
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4-aminoquinoline hybrid evaluated using Lipinski’s 
rule of five. This evaluation is beneficial to predict 
4-aminoquinoline hybrid drug likeliness characteristics 
before the compound designed is synthesized (Kalita 
et al. 2019; Lipinski et al. 1997). The result depicted 
in Table 3 shows that all designed molecules possess 
acceptable drug-like properties. Five newly designed 
4-aminoquinoline hybrid appeared to adhere to all the rules 
with only one violation while the remaining derivatives 
adhered entirely to the rules with two violations. The 
molecular weight of all the compounds exceeded 500 
g/mol, while the log P value of 5 of the compounds is 
higher than five. Poor oral absorption of a drug molecule 
observed if the drug molecule violates more than one of 
five rules. Values of log P and molecular weight indicate 
good membrane permeability and oral bioavailability 
of compounds. Further modification on their structure 
would be necessary to refine their ability as a drug from 
Lipinski’s rule evaluation. Ultimately, it can be suggested 
that the newly designed 4-aminoquinoline hybrid mainly 
compound 8 poses acceptable drug-likeliness behaviour 
favourable for membrane permeability with desired drug-
receptor interaction.
TABLE 1. Binding affinity (kcal/mol) of the favourable conformation based on 
AutoDock Vina
Compounds





1 -6.8 -34.8243 -64.5686
2 -7.1 -34.917 -79.3903
3 -7.0 -38.4815 -75.6134
4 -6.9 -33.4367 -90.9865
5 -6.9 -33.5367 -88.9353
6 -6.4 -32.0062 -83.6099
7 -6.3 -30.5239 -67.1933
8 -7.0 -32.8165 -74.6616
9 -6.8 -32.4649 -69.0346
10 -6.4 -35.8242 -58.9628
chloroquine -5.9 -30.8754 -61.7052
amodiaquine -5.6 -32.2669 -66.3134
hydroxychloroquine -5.9 -32.3515 -56.6754
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FIGURE 2. Superposition of the chloroquine crystal structure as observed 
in the crystallographic structure of the PfLDH enzyme and the best 
docking conformation obtained for chloroquine crystal structure(green) 
docked inside the same active site using AutoDock Vina(1), Molegro 
Virtual Docker(2) and CDOCKER(3)
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FIGURE 3. The residue of the binding site of P. falciparum lactate 
dehydrogenase (PfLDH) enzyme interacting with compound 8 using 
Autodock Vina
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GLU122 - - /
ASN83 / -
Van der Waals  
PHE100 - - /
GLU122 / - -
ILE123 / - -
TYR85 / - -
Alkyl & 
π-alkyl
1LE54 - / /
ILE119 - / /
ALA98 / / -
PHE52 / / -
VAL26 / / -
π-sigma
ALA98 - - /
ILE54 / - -
ILE119 / - -
 
C A B 
FIGURE 4. The residue of the binding site of P. falciparum lactate 
dehydrogenase (PfLDH) enzyme interacting with chloroquine
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weight < 500 
g/mol
1 5.14 3 10 558.5
2 5.51 3 8 592.5
3 5.21 4 9 608.5
4 5.10 4 9 565
5 4.81 3 8 529.5
6 4.11 3 8 520.5
7 6.06 3 8 536.5
8 3.39 4 9 542.5
9 2.59 4 10 539.5
10 3.46 4 10 565.5
chloroquine 4.81 1 3 319.5
amodiaquine 5.17 2 4 355.5
hydroxychloroquine 3.78 2 4 335.5
CONCLUSION
Ten 4-aminoquinoline hybrid compounds docked to 
the PfLDH putative binding site using AutoDock Vina, 
Molegro Virtual Docker, and CDOCKER. All of them 
have shown promising binding affinity in comparison 
with chloroquine, amodiaquine, and hydroxychloroquine 
thus could suggest their strong binding interaction to 
act as a competitor for this critical glycolytic enzyme. 
Among them, compound 8 displayed the potential 
binding affinity besides having conformation that fit 
into chloroquine binding site. It exhibited similar 
interactions with the amino acid residues as per 
chloroquine with additional hydrogen bond formation. 
Drug likeliness studies confirmed likely compound 8 as 
a potential drug. Our present work has provided further 
understanding of the binding mode and interaction of 
these 4-aminoquinoline hybrids with the PfLDH enzyme, 
thus become a reasonable basis towards further molecular 
optimization of 4-aminoquinoline hybrid as a potential 
antimalarial.   
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